89 related articles for article (PubMed ID: 9299282)
1. Phosphodiesterase inhibition overcomes pulmonary vasomotor dysfunction in acute lung injury.
Sheridan BC; McIntyre RC; Meldrum DR; Fullerton DA
J Surg Res; 1997 Aug; 71(2):145-9. PubMed ID: 9299282
[TBL] [Abstract][Full Text] [Related]
2. Pentoxifylline treatment attenuates pulmonary vasomotor dysfunction in acute lung injury.
Sheridan BC; McIntyre RC; Meldrum DR; Fullerton DA
J Surg Res; 1997 Aug; 71(2):150-4. PubMed ID: 9299283
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension in acute lung injury is due to impaired vasodilation with intact vascular contractility.
McIntyre RC; Banerjee A; Agrafojo J; Fullerton DA
J Surg Res; 1995 Jun; 58(6):765-70. PubMed ID: 7791358
[TBL] [Abstract][Full Text] [Related]
4. Dysfunction of cGMP-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury.
Fullerton DA; McIntyre RC; Hahn AR; Agrafojo J; Koike K; Meng X; Banerjee A; Harken AH
Am J Physiol; 1995 Jun; 268(6 Pt 1):L1029-35. PubMed ID: 7611425
[TBL] [Abstract][Full Text] [Related]
5. L-arginine attenuates endothelial dysfunction in endotoxin-induced lung injury.
Sheridan BC; McIntyre RC; Meldrum DR; Fullerton DA
Surgery; 1999 Jan; 125(1):33-40. PubMed ID: 9889795
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil depletion attenuates endotoxin-induced dysfunction of cGMP-mediated pulmonary vasorelaxation.
Sheridan BC; McIntyre RC; Agrafojo J; Meldrum DR; Meng X; Fullerton DA
Am J Physiol; 1996 Nov; 271(5 Pt 1):L820-8. PubMed ID: 8944726
[TBL] [Abstract][Full Text] [Related]
7. Endotoxin stuns cGMP-mediated pulmonary vasorelaxation.
Sheridan BC; McIntyre RC; Meldrum DR; Meng X; Fullerton DA
Shock; 1997 Sep; 8(3):207-12. PubMed ID: 9377168
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent effects of a selective phosphodiesterase-5-inhibitor on endothelial dysfunction induced by peroxynitrite in rat aorta.
Korkmaz S; Radovits T; Barnucz E; Neugebauer P; Arif R; Hirschberg K; Loganathan S; Seidel B; Karck M; Szabó G
Eur J Pharmacol; 2009 Aug; 615(1-3):155-62. PubMed ID: 19482016
[TBL] [Abstract][Full Text] [Related]
9. Vinblastine attenuates endotoxin-induced impairment of CGMP-mediated pulmonary vasorelaxation.
Sheridan BC; McIntyre RC; Meldrum DR; Cleveland JC; Agrafojo J; Eisenach JH; Fullerton DA
Shock; 1996 Jul; 6(1):35-8. PubMed ID: 8828082
[TBL] [Abstract][Full Text] [Related]
10. Endothelium-dependent and -independent vasorelaxation by a theophylline derivative MCPT: roles of cyclic nucleotides, potassium channel opening and phosphodiesterase inhibition.
Lo YC; Tsou HH; Lin RJ; Wu DC; Wu BN; Lin YT; Chen IJ
Life Sci; 2005 Jan; 76(8):931-44. PubMed ID: 15589969
[TBL] [Abstract][Full Text] [Related]
11. Cold ischemia and reperfusion each produce pulmonary vasomotor dysfunction in the transplanted lung.
Fullerton DA; Mitchell MB; McIntyre RC; Banerjee A; Campbell DN; Harken AH; Grover FL
J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1213-7. PubMed ID: 8246563
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary vascular smooth muscle relaxation by cGMP- versus cAMP-mediated mechanisms.
Fullerton DA; Hahn AR; Banerjee A; Harken AH
J Surg Res; 1994 Aug; 57(2):259-63. PubMed ID: 7913147
[TBL] [Abstract][Full Text] [Related]
13. Endothelium-dependent pulmonary artery vasorelaxation is dysfunctional in males but not females after acute lung injury.
Tsai BM; Wang M; Pitcher JM; Kher A; Brown JW; Meldrum DR
Surgery; 2005 Jul; 138(1):78-84. PubMed ID: 16003320
[TBL] [Abstract][Full Text] [Related]
14. Intracellular mechanisms of pulmonary vasomotor dysfunction in acute lung injury caused by mesenteric ischemia-reperfusion.
Fullerton DA; Hahn AR; Koike K; Banerjee A; Harken AH
Surgery; 1993 Aug; 114(2):360-6; discussion 366-7. PubMed ID: 8393598
[TBL] [Abstract][Full Text] [Related]
15. Neutrophils mediate pulmonary vasomotor dysfunction in endotoxin-induced acute lung injury.
Sheridan BC; McIntyre RC; Moore EE; Meldrum DR; Agrafojo J; Fullerton DA
J Trauma; 1997 Mar; 42(3):391-6; discussion 396-7. PubMed ID: 9095105
[TBL] [Abstract][Full Text] [Related]
16. Cyclic GMP potentiation by WIN 58237, a novel cyclic nucleotide phosphodiesterase inhibitor.
Silver PJ; Dundore RL; Bode DC; de Garavilla L; Buchholz RA; van Aller G; Hamel LT; Bacon E; Singh B; Lesher GY
J Pharmacol Exp Ther; 1994 Dec; 271(3):1143-9. PubMed ID: 7996419
[TBL] [Abstract][Full Text] [Related]
17. Role of protein kinase G in nitric oxide deficiency-induced supersensitivity to nitrovasodilator in rat pulmonary artery.
Gupta PK; Subramani J; Singh TU; Leo MD; Sikarwar AS; Prakash VR; Mishra SK
J Cardiovasc Pharmacol; 2008 May; 51(5):450-6. PubMed ID: 18418274
[TBL] [Abstract][Full Text] [Related]
18. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
[TBL] [Abstract][Full Text] [Related]
19. NO prevents neutrophil-mediated pulmonary vasomotor dysfunction in acute lung injury.
Friese RS; Fullerton DA; McIntyre RC; Rehring TF; Agrafojo J; Banerjee A; Harken AH
J Surg Res; 1996 Jun; 63(1):23-8. PubMed ID: 8661166
[TBL] [Abstract][Full Text] [Related]
20. Enhanced prostanoid-mediated vasorelaxation in pulmonary arteries isolated during experimental endotoxemia.
Myers TP; Myers PR; Adams HR; Parker JL
Shock; 1999 Jun; 11(6):436-42. PubMed ID: 10454834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
